News und Analysen
3 Growth Stocks I'd Buy Right Now
What's a six-letter word that's guaranteed to make investors happy? Growth. While growth comes in several flavors, they're all interrelated. Growth in revenue helps make earnings growth possible,....
Why Celldex Therapeutics Stock Reversed Course in November
Shares of the struggling small-cap biotech Celldex Therapeutics (NASDAQ: CLDX) finally showed some signs of life in November. Specifically, the biotech's stock rose by a healthy 27.6% last....
Better Buy: Pfizer (PFE) vs. AbbVie (ABBV)
For Pfizer (NYSE: PFE), 2017 so far has looked better than the past couple of years in terms of stock performance. However, the stock's 9% year-to-date gain isn't anything to jump up and down....
The Individual Mandate: We Hate It, but We Need It
Big change is afoot in Washington, and it has nothing to do with the weather. Republicans in both houses of Congress have passed their respective version of tax reform and now are working on a few....
The Individual Mandate: We Hate It, but We Need It
Big change is afoot in Washington, and it has nothing to do with the weather. Republicans in both houses of Congress have passed their respective version of tax reform and now are working on a few....
3 Top Stocks Under $10
There's cheap, then there's cheap. Some stocks are cheap in the sense of the definition of the word relating to relatively low price compared to their potential value. Others are cheap under....
Will Johnson & Johnson Raise Its Dividend in 2018?
Just about everyone has some products from Johnson & Johnson (NYSE: JNJ) in their medicine cabinets, ranging from over-the-counter medicines like Tylenol and Benadryl to Band-Aid bandages. Yet....
Will Johnson & Johnson Raise Its Dividend in 2018?
Just about everyone has some products from Johnson & Johnson (NYSE: JNJ) in their medicine cabinets, ranging from over-the-counter medicines like Tylenol and Benadryl to Band-Aid bandages. Yet....
Better Buy: Intuitive Surgical, Inc. vs. Accuray, Inc.
New drugs that improve treatment often get a lot of attention. But in recent years some medical devices have arguably had just as much impact as many of these drugs. Two companies making such....
Better Buy: Intuitive Surgical, Inc. vs. Accuray, Inc.
New drugs that improve treatment often get a lot of attention. But in recent years some medical devices have arguably had just as much impact as many of these drugs. Two companies making such....
Better Buy: Intuitive Surgical, Inc. vs. Accuray, Inc.
New drugs that improve treatment often get a lot of attention. But in recent years some medical devices have arguably had just as much impact as many of these drugs. Two companies making such....
What Happened in the Stock Market Today
Stocks finished the week on a positive note Friday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) in positive territory throughout the session and....
Here's Why Radius Health Is Rising Today
After presenting data from a phase 1 study at a medical conference, shares of Radius Health (NASDAQ: RDUS), a commercial-stage biotech focused on osteoporosis and cancer, rose 15% as of 11:15 a.m.....
A Game-Changing Breakthrough Could Be Coming for Hemophilia Patients
Patients diagnosed with hemophilia B suffer a lifetime of treatment, but that could change based on recently reported data from an early stage trial Pfizer (NYSE: PFE) and Spark Therapeutics....
Immunomedics' Data Is Good News for Seattle Genetics, Too
Seattle Genetics' (NASDAQ: SGEN) deal to license Immunomedics' (NASDAQ: IMMU) sacituzumab govitecan, a breast cancer drug, was shelved earlier this year when activist investor venBio Select....
Immunomedics' Data Is Good News for Seattle Genetics, Too
Seattle Genetics' (NASDAQ: SGEN) deal to license Immunomedics' (NASDAQ: IMMU) sacituzumab govitecan, a breast cancer drug, was shelved earlier this year when activist investor venBio Select....
Why Sage Therapeutics Gained 70% Today
Shares of Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biotech, took flight today, after the company announced positive mid-stage trial results for its moderate-to-severe major depressive....
What Happened in the Stock Market Today
Stocks moved higher on Thursday, with the Dow Jones Industrial Average (DJINDICES: ^DJI) and the S&P 500 (SNPINDEX: ^GSPC) both up a little more than a quarter percentage point.Data source:....
Here's Why Marinus Pharmaceuticals Rose as Much as 41.1% Thursday
Shares of clinical-stage biopharma Marinus Pharmaceuticals (NASDAQ: MRNS) rose over 41% today after larger peer Sage Therapeutics (NASDAQ: SAGE) reported positive top-line results for one of its....
Is Exelixis, Inc. a Buy?
Yes.I know I'm breaking all the rules about building up suspense, etc. But I think Exelixis (NASDAQ: EXEL) is a buy right now. I think the stock will go higher over the next few years. Don't just....
Is Exact Sciences Corporation (EXAS) a Buy?
Some investors look at a stock that has nearly quadrupled in price within less than 12 months and are excited about buying it. Others look at the same stock and are afraid that the momentum could....
Here's What Caused Sarepta Therapeutics to Shoot 13% Higher In November
A month full of news related to the progress it's making toward helping patients with Duchenne muscular dystrophy (DMD) sparked a 12.9% rally in Sarepta Therapeutics (NASDAQ: SRPT) shares last....
Here's What Caused This Marijuana Stock to Skyrocket 15% in November
Medical marijuana has been used to treat epilepsy in patients for years, but so far, it's efficacy and safety hasn't been supported by a regulatory green light from the Food and Drug....
These 3 Healthcare Stock Dividends Could Soar If Trump Signs a Tax Reform Bill
Now that tax reform bills featuring 20% tax rates have passed the House and Senate, it looks like companies across the country will get to distribute a lot more of the profits they generate. Of....
These 3 Healthcare Stock Dividends Could Soar If Trump Signs a Tax Reform Bill
Now that tax reform bills featuring 20% tax rates have passed the House and Senate, it looks like companies across the country will get to distribute a lot more of the profits they generate. Of....